- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
The pharmaceutical market in Singapore is set to rise from $948 million in 2017 to around $1.2 billion in 2021, and will first exceed the $1 billion mark in 2019, according to GlobalData, a recognized leader in providing business information and analytics.
Consumers now more concerned about mental wellbeing than physical fitness
Driven by increasingly digital lifestyles and a more holistic understanding of health and wellbeing, the demand for products that address health beyond diet and fitness is growing, according to GlobalData, a recognized leader in providing business information and analytics.
COPD market set to hit $14.1 billion by 2025, with AstraZeneca and GSK making strides
The chronic obstructive pulmonary disease (COPD) space across the eight major markets of the US, France, Germany, Italy, Spain, the UK, Japan, and Australia, is set to rise from $9.9 billion in 2015 to around $14.1 billion by 2025, representing a compound annual growth rate of 3.7%, according to GlobalData, a recognized leader in providing business information and analytics.
UK election poll: Aldi and Lidl shoppers want Conservative victory
As part of GlobalData’s regular Consumer Sentiment Tracker, we conducted a survey in the run-up to the election to discover the voting intentions of supermarket shoppers.
Venous thromboembolism (VTE) market will see strong growth to 2026, hitting $2.85 billion
The venous thromboembolism (VTE) space across the seven major markets of the US, France, Germany, Italy, Spain, the UK, and Japan, is set to rise from $1.95 billion in 2016 to around $2.85 billion by 2026, representing a strong compound annual growth rate (CAGR) of 3.87%, according to GlobalData, a recognized leader in providing business information and analytics.
Product personalization and lifestyle choices now more important than traditional consumer demographics
Lifestyle-focused consumers are increasingly seeking products personalized to their individual preferences rather than those corresponding to traditional demographic stereotypes, according to GlobalData, a recognized leader in providing business information and analytics.
Serving recent migrants among niches targeted by new digital banks
Several new digitally based banks have entered the market recently, aided by new technology and efforts by financial regulators to create a more favorable environment. However, success is far from guaranteed and, in order to prosper, new entrants need to develop distinctive propositions that set them apart from established providers, according to GlobalData, a recognized leader in providing business information and analytics.
Rising obesity in young people boosting £5 billion UK plus size womenswear market
One in every £5 spent on womenswear in 2017 will be spent on plus size garments, according to GlobalData, a recognized leader in providing business information and analytics.
No unified mobile payments landscape in sight
The gap in mobile payments technology between developing and developed markets means that mobile wallets cannot replace payment cards as international payment tools, according to GlobalData, a recognized leader in providing business information and analytics.
European revision knee replacement market to see modest rise to $304m by 2023
The European revision knee replacement market, which covers 21 countries, is set to rise modestly from around $259m in 2016 to just over $304m by 2023, representing a compound annual growth rate of 2.3%, according to GlobalData, a recognized leader in providing business information and analytics.
Growth hormone deficiency market to grow steadily, surpassing $2 billion by 2026
The global growth hormone deficiency (GHD) space, which covers the seven major markets of the US, France, Germany, Italy, Spain, the UK, and Japan, is set to rise from around $1.42 billion in 2016 to $2.08 billion by 2026, representing a steady compound annual growth rate (CAGR) of 3.9%, according to GlobalData, a recognized leader in providing business information and analytics.
North American artificial disc replacement market set to reach $614.5 million by 2023
The North American artificial disc replacement (ADR) market, which covers Canada, Mexico, and the US, is set to more than double from $274.6 million in 2016 to around $614.5 million by 2023, representing a compound annual growth rate of 12.2%, according to GlobalData, a recognized leader in providing business information and analytics.
Long-acting therapies could transform HIV treatment by boosting compliance
One of the most pressing unmet needs in the human immunodeficiency virus (HIV) market, which is set to reach $22.5 billion by 2025, lies in the current lack of long-acting and safer treatments, according to GlobalData, a recognized leader in providing business information and analytics.
Non-alcoholic steatohepatitis (NASH) market will increase more than fortyfold by 2026
The non-alcoholic steatohepatitis (NASH) space across the seven major markets of the US, France, Germany, Italy, Spain, the UK, and Japan, is set to rise from $618 million in 2016 to around $25.3 billion by 2026, representing a very rapid compound annual growth rate of 45%, according to GlobalData, a recognized leader in providing business information and analytics.
Stable economy will drive German pharmaceuticals market to $86.3 billion by 2021
The German pharmaceuticals market is set to rise from $67.9 billion (€52.9 billion) in 2016 to around $86.3 billion (€67.2 billion) in 2021, representing a compound annual growth rate of 4.9%, according to GlobalData, a recognized leader in providing business information and analytics.
UK millennials are not mass market insurance consumers
Millennials have different priorities and lifestyles compared to previous generations, which means their insurance needs do not fit the standard packaged products currently on the market, according to GlobalData, a recognized leader in providing business information and analytics.
UK retail parks will grow faster than high streets to 2022
The UK retail parks market is expected to grow by 13.8% between 2017 and 2022, with the sector set to outperform the high street, according to GlobalData, a recognized leader in providing business information and analytics.
Political uncertainties are driving European HNW wealth offshore
Wealth managers have to understand the reasons why High Net Worth (HNW) investors want to channel their assets offshore, and design their service propositions accordingly. In Europe, this means risk mitigation has to become a more prominent theme in a provider’s international investment offering, according to GlobalData, a recognized leader in providing business information and analytics.
Spain’s pharmaceutical market set to show signs of stability, surpassing $25 billion by 2021
The Spanish pharmaceutical market is set to see a slight rise in value from $23.7 billion in 2016 to $25.1 billion by 2021, registering a compound annual growth rate approaching 1%, according to GlobalData, a recognized leader in providing business information and analytics.
Marketplace banking will transform the provision of financial services
The era of “open banking,” in which banks will have to allow third parties direct access to customer data, is fast approaching, and the most ambitious banks will use this concept to turn themselves into marketplaces where consumers can access products from a variety of providers, according to GlobalData, a recognized leader in providing business information and analytics.